approved

Приложение 4 на ПЛС от 02.04.2020 г.

Unique identificator:  16567f8c-dc9e-43f9-aafb-76a24c493a59

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-04-02 14:27:22
  • Created by: georgi_sivchev
  • Updated at: 2020-04-02 14:27:22
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Apixaban EU/1/11/619/003 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 111.48 22.3 133.78 4% 4.46 115.94 23.19 139.13 16% 17.84 133.78 26.76 160.54 НСР-4898/22.10.2014 06.11.2014 06.11.2014 Неактивен 3266
Apixaban EU/1/11/691/009 ELIQUIS, Film coated tablet, 5, mg, Pack: 60 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L.,Италия 111.48 22.3 133.78 4% 4.46 115.94 23.19 139.13 16% 17.84 133.78 26.76 160.54 НСР-3604/23.05.2014 06.06.2014 06.06.2014 Неактивен 2819
Apixaban EU/1/11/619/003 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy 113.83 22.77 136.6 4% 4.55 118.38 23.68 142.06 16% 18.21 136.59 27.32 163.91 НСР-2498/24.01.2014 12.02.2014 12.02.2014 Неактивен 3266
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy 37.94 7.59 45.53 4% 1.52 39.46 7.89 47.35 16% 6.07 45.53 9.11 54.64 НСР-2498/24.01.2014 12.02.2014 12.02.2014 Неактивен 3266
Apixaban EU/1/11/691/009 ELIQUIS, Film coated tablet, 5, mg, Pack: 60 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L.,Италия 121.24 24.25 145.49 4% 4.85 126.09 25.22 151.31 16% 19.4 145.49 29.1 174.59 НСР-1036/23.08.2013 11.09.2013 11.09.2013 Неактивен 2819
Apixaban EU/1/11/619/003 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy 132.72 26.54 159.26 4% 5.31 138.03 27.61 165.64 16% 21.24 159.27 31.85 191.12 корекц. КЦPP-2717/20.03.2013 КЦРР-2413/22.02.2013 17.04.2013 17.04.2013 Неактивен 3266
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy 44.24 8.85 53.09 4% 1.77 46.01 9.2 55.21 16% 7.08 53.09 10.62 63.71 корекц. КЦPP-2717/20.03.2013 КЦРР-2413/22.02.2013 17.04.2013 17.04.2013 Неактивен 3266
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Ирландия Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 35.19 7.04 42.23 4% 1.41 36.6 7.32 43.92 16% 5.63 42.23 8.45 50.68 Промяна на обстоятелства НСР-20070/30.10.2019 НСР-4899/22.10.2014; НСР-9829/21.07.2016; НСР-12835/26.05.2017; НСР-15143/02.03.2018 17.03.2018 02.12.2019 Активен 3265
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 35.19 7.04 42.23 4% 1.41 36.6 7.32 43.92 16% 5.63 42.23 8.45 50.68 НСР-4899/22.10.2014; НСР-9829/21.07.2016; НСР-12835/26.05.2017; НСР-15143/02.03.2018 17.03.2018 02.04.2018 Неактивен 3265
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 36.81 7.36 44.17 4% 1.47 38.28 7.66 45.94 16% 5.89 44.17 8.83 53 НСР-4899/22.10.2014; НСР-9829/21.07.2016; НСР-12835/26.05.2017 10.06.2017 02.07.2017 Неактивен 3265
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 36.87 7.37 44.24 4% 1.47 38.34 7.67 46.01 16% 5.9 44.24 8.85 53.09 НСР-4899/22.10.2014; НСР-9829/21.07.2016 02.09.2016 02.09.2016 Неактивен 3265
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 36.87 7.37 44.24 4% 1.47 38.34 7.67 46.01 16% 5.9 44.24 8.85 53.09 НСР-4899/22.10.2014; НСР-9829/21.07.2016 02.09.2016 02.09.2016 Неактивен 3265
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 37.16 7.43 44.59 4% 1.49 38.65 7.73 46.38 16% 5.95 44.6 8.92 53.52 НСР-4899/22.10.2014 06.11.2014 06.11.2014 Неактивен 3265
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 37.16 7.43 44.59 4% 1.49 38.65 7.73 46.38 16% 5.95 44.6 8.92 53.52 НСР-4899/22.10.2014 06.11.2014 06.11.2014 Неактивен 3265
Metoclopramide 20160367 Elitan, Solution for injection, 10 mg/2 ml, mg, Pack: 100 Medochemie Ltd., Кипър Medochemie Ltd., Кипър 97.79 19.56 117.35 4% 3.91 101.7 20.34 122.04 16% 15.65 117.35 23.47 140.82 НСР-12407/18.04.2017 и НСР-12549/28.04.2017 (предварително изпълнение) НСР-11549/26.01.2017 г. 11.02.2017 02.05.2017 Активен 15587
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/001 Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 306.2 61.24 367.44 4% 10 316.2 63.24 379.44 16% 25 341.2 68.24 409.44 НСР-18704/20.05.2019 и КП-86/14.11.2019 НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 02.08.2019 02.01.2020 Активен 15666
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/001 Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 306.2 61.24 367.44 4% 10 316.2 63.24 379.44 16% 25 341.2 68.24 409.44 НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 02.08.2019 02.08.2019 Неактивен 15666
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1224.78 244.96 1469.74 4% 10 1234.78 246.96 1481.74 16% 25 1259.78 251.96 1511.74 НСР-18709/20.05.2019 и КП-86/14.11.2019 НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 02.08.2019 02.01.2020 Активен 15668
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1224.78 244.96 1469.74 4% 10 1234.78 246.96 1481.74 16% 25 1259.78 251.96 1511.74 НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 02.08.2019 02.08.2019 Неактивен 15668
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1224.78 244.96 1469.74 4% 10 1234.78 246.96 1481.74 16% 25 1259.78 251.96 1511.74 НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 02.08.2019 02.08.2019 Неактивен 15668
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/001 Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 306.2 61.24 367.44 4% 10 316.2 63.24 379.44 16% 25 341.2 68.24 409.44 НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 02.08.2019 02.08.2019 Неактивен 15666
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/001 Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 316.84 63.37 380.21 4% 10 326.84 65.37 392.21 16% 25 351.84 70.37 422.21 НСР-12362/18.04.2017; НСР-15072/23.02.2018 10.03.2018 02.04.2018 Неактивен 15666
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1267.38 253.48 1520.86 4% 10 1277.38 255.48 1532.86 16% 25 1302.38 260.48 1562.86 НСР-12362/18.04.2017; НСР-15073/23.02.2018 10.03.2018 02.04.2018 Неактивен 15668
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/001 Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 352.05 70.41 422.46 4% 10 362.05 72.41 434.46 16% 25 387.05 77.41 464.46 НСР-12362/18.04.2017 03.05.2017 02.06.2017 Неактивен 15666
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1408.2 281.64 1689.84 4% 10 1418.2 283.64 1701.84 16% 25 1443.2 288.64 1731.84 НСР-12362/18.04.2017 03.05.2017 02.06.2017 Неактивен 15668
Showing 4526 to 4551 of 17264 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте